‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long - The Washington Post

1. ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long  The Washington Post
2. Daily pill can double survival time for world’s deadliest cancer, trial shows  The Guardian
3. Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program  Le Monde.fr
4. Daraxonrasib significantly extends survival in metastatic pancreatic cancer  News-Medical
5. RASolute 302 Brings a “Transformative" Moment in Pancreatic Cancer: A 60% Improvement in Overall Survival  AJMC

from Top stories - Google News https://ift.tt/u8GTaqf